BioSpace News Archive

To showcase Canon eyecare technology and teleretinal solutions to vision professionals from across the globe, Canon U.S.A., Inc., a leader in digital imaging solutions, will be on-site for Vision Expo West from Thursday, September 27 through Saturday, September 29 at the Sands Expo in Las Vegas, Nevada.

Equipped with knowledge and backed by rich industry experience, British Biologicals, an award-winning global nutraceutical company, has announced Bharath Reddy, Director of International Business Development and Operations, will lead the company’s expansion into the United States for an end-to-end solution for the nutritional supplement industry.

Trial Results Published in Circulation

Med-X, Inc.'s green pesticide product division, Nature-Cide, announced today that it has signed a direct distribution deal with one of the nation’s leading green-focused pest control service companies, Pestmaster Services.

Demerger clears the path for therapeutic company capital raising

First Approved Oncology Treatment From Amgen Astellas Joint Venture

At its 2018 awards gala, BioAlberta, the province’s life sciences industry association, recognized two leaders for their innovation and achievements. BioAlberta congratulates Circle Cardiovascular Imaging Inc. for winning its Company of the Year award and Dr. John Lewis for winning its Scientific Achievement and Innovation Award.

Physicians have long recommended fish oil to patients with high cholesterol and triglycerides, even though the scientific studies on it are mixed. Amarin developed a drug called Vascepa, which derives from a purified component of fish oil called eicosapentaenoic acid (EPA).

AstraZeneca announced positive results from its Phase III DECLARE-TIMI 58 cardiovascular outcomes clinical trial of Farxiga (dapagliflozin).

Epizyme, an innovative epigenetic therapy development company, announced this morning that the U.S. Food and Drug Administration has removed their former partial clinical hold reported in April of this year.